Molica M. SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY: Long-lasting disease remission with third line therapy with gilteritinib. Mediterr J Hematol Infect Dis [Internet]. 2024 Oct. 31 [cited 2024 Nov. 21];16(1):e2024079. Available from: https://www.mjhid.org/mjhid/article/view/5835